Intron Biotech
rapid medical diagnostics
"Better healthcare
outcomes begin
with better
diagnosis
"
Point of care testing (POCT), rapid medical diagnostics and medical electronics for fertility, infectious diseases, drugs of abuse, tumor markers, cardiac markers, blood glucose monitoring and urinalysis.
Manufacturing Facilities
Point of care testing (POCT), rapid medical diagnostics and medical electronics for fertility, infectious diseases, drugs of abuse, tumor markers, cardiac markers, blood glucose monitoring and urinalysis. Our contracted manufacturing facilities are located in San Diego, California and in Hangzhou, China.

Both facilities are FDA registered manufacturers of Rapid Medical Diagnostic products and they have been awarded GMP certification by the US and the Chinese government.

Millions of rapid test kits are produced in these facilities to support our world wide distribution network supplying hospitals, clinical laboratories, blood banks and consumer outlets.



Forces Driving the Market
for Point of Care Testing
Government: Focused on reducing hospital length of stay and patient treatment via out care models (eg. homecare)

Technology: Making lab quality tests available close to doctors office, patient's home and in ICU's and delivered by non-laboratory personnel.

Point of care testing (POCT), rapid medical diagnostics and medical electronics for fertility, infectious diseases, drugs of abuse, tumor markers, cardiac markers, blood glucose monitoring and urinalysis.

Social & economic pressure: Increased patient empowerment and health consciousness.

Decision makers: Physicians, Lab directors, Nurses, point of care coordinators and hospital administrators.

Information technology: Focused on faster delivery of test results to drive faster therapeutic intervention.